The pathogenesis and treatment of polycystic ovary syndrome: What's new?
S Bednarska, A Siejka - Advances in Clinical and …, 2017 - publicum.umed.lodz.pl
Polycystic ovary syndrome (PCOS) is currently the leading cause of menstrual complications
in women. It is characterized by clinical and/or biochemical hyperandrogenism, ovulation …
in women. It is characterized by clinical and/or biochemical hyperandrogenism, ovulation …
Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena
Introduction Polycystic ovary syndrome (PCOS) is associated with numerous metabolic
morbidities (insulin resistance (IR), central obesity) and various nutritional abnormalities …
morbidities (insulin resistance (IR), central obesity) and various nutritional abnormalities …
[HTML][HTML] Polycystic ovary syndrome and its management: In view of oxidative stress
K Bhattacharya, R Dey, D Sen, N Paul… - Biomolecular …, 2024 - degruyter.com
In the past two decades, oxidative stress (OS) has drawn a lot of interest due to the
revelation that individuals with many persistent disorders including diabetes, polycystic …
revelation that individuals with many persistent disorders including diabetes, polycystic …
Recent advances in the treatment of polycystic ovary syndrome
BO Yildiz - Expert opinion on investigational drugs, 2004 - Taylor & Francis
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disorder that presents
a challenge for clinical investigators. It is the most common endocrine disorder of …
a challenge for clinical investigators. It is the most common endocrine disorder of …
Polycystic ovary syndrome: from physiopathology to therapy
M Vicino, V Loizzi, D Scardigno, L Selvaggi - Minerva Ginecologica, 2006 - europepmc.org
Polycystic ovary syndrome (PCOS) is still a complex and heterogeneous disorder that
presents a challenge for clinical investigators. It is the most common endocrine and …
presents a challenge for clinical investigators. It is the most common endocrine and …
[PDF][PDF] Polycystic ovary syndrome: a brief review with recent updates
S Shermin, A Noor, S Jahan - Delta Medical College …, 2019 - pdfs.semanticscholar.org
Polycystic ovary syndrome (PCOS) is a chronic, complex and the most common endocrine
disorder observed in women of reproductive age. This syndrome is heterogeneous by …
disorder observed in women of reproductive age. This syndrome is heterogeneous by …
Management of polycystic ovary syndrome
E Yasmin, AH Balen - Women's Health, 2007 - journals.sagepub.com
Polycystic ovary syndrome is a common endocrinological problem in women of reproductive
age. Polycystic ovary syndrome is a heterogenous disorder and patients may attend different …
age. Polycystic ovary syndrome is a heterogenous disorder and patients may attend different …
New perspectives on the definition and management of polycystic ovary syndrome
R Pasquali, A Gambineri - Journal of Endocrinological Investigation, 2018 - Springer
Background There is a growing debate on the opportunity of improving the understanding in
the diagnosis and management of polycystic ovary syndrome (PCOS). Objective This review …
the diagnosis and management of polycystic ovary syndrome (PCOS). Objective This review …
Polycystic ovary syndrome—a systemic disorder?
A Balen, M Rajkowha - Best Practice & Research Clinical Obstetrics & …, 2003 - Elsevier
Polycystic ovary syndrome (PCOS) is the commonest endocrine disturbance affecting
women. There is considerable heterogeneity of symptoms and signs amongst women with …
women. There is considerable heterogeneity of symptoms and signs amongst women with …
The diagnosis and the reproductive and metabolic consequences of polycystic ovary syndrome
M AbuFaza, IA Abdelazim, P Purohit… - Journal of Obstetrics …, 2018 - termedia.pl
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women
in their reproductive age, with significant reproductive, metabolic and psychological …
in their reproductive age, with significant reproductive, metabolic and psychological …